Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Perceptual and Motor Skills|April 15, 2014
Influence of acute high-intensity aerobic interval exercise bout on selective attention and short-term memory tasksChristiano R R Alves, Victor H Tessaro, Luis A C Teixeira, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Engineered CRISPR-Base Editors as a Permanent Treatment for Familial DysautonomiaShuqi Yun, Anil Chekuri, Jennifer Art, et al.
Gene Therapy|April 1, 2025
Early life safety profiling of gene therapy for spinal muscular atrophyRebecca G Spellman, Leillani L Ha, Salomé Da Silva Duarte Lepez, et al.
Plant Physiology and Biochemistry : PPB|December 27, 2017
The contribution of weak CAM to the photosynthetic metabolic activities of a bromeliad species under water deficitFilipe C Pikart, Mauro A Marabesi, Paulo T Mioto, et al.
Annals of Clinical and Translational Neurology|May 15, 2021
Increased systemic HSP70B levels in spinal muscular atrophy infantsEric J Eichelberger, Christiano R R Alves, Ren Zhang, et al.
Life Sciences|October 15, 2017
Effects of N-acetylcysteine on isolated skeletal muscle contractile properties after an acute bout of aerobic exercisePaulo R Jannig, Christiano R R Alves, Vanessa A Voltarelli, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Poison exon splicing in the human brain: a new frontier for understanding and targeting neurological disordersPaolo Pigini, Huilin Xu, Yan Ji, et al.
BMJ Case Reports|July 15, 2026
Managing nusinersen therapy during pregnancy in spinal muscular atrophy type 3Leillani L Ha, Caitlin Thomas, Kiersten Pease, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 12, 2007
Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapyM C Pereira-Santos, A P Baptista, A Melo, et al.
European Journal of Neurology|May 5, 2022
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patientsIddo Magen, Sharon Aharoni, Nancy Sarah Yacovzada, et al.
Pageof 5